|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | University of Alabama at Birmingham |
|---|---|
| Collaborator: |
American Society of Regional Anesthesia |
| Information provided by: | University of Alabama at Birmingham |
| ClinicalTrials.gov Identifier: | NCT00659633 |
Purpose
The purpose of this study is to study if lidocaine, given intravenously, reduces pain.
| Condition | Intervention |
|---|---|
|
Pain |
Drug: lidocaine |
| Study Type: | Interventional |
| Study Design: | Treatment, Open Label, Dose Comparison, Single Group Assignment, Efficacy Study |
| Official Title: | The Effect of Intravenous Lidocaine on Allodynia (Carl Koller Grant) |
| Estimated Enrollment: | 10 |
| Study Start Date: | December 2008 |
| Estimated Primary Completion Date: | July 2010 (Final data collection date for primary outcome measure) |
Clinicians use lidocaine intravenously in a fashion that suggests that it might have analgesic effects. Therefore, we test the hypothesis that lidocaine reduces pain intensity in response to experimental pain.
Eligibility| Ages Eligible for Study: | 19 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Debbie Owen, BS | 205-975-2088 | debbieo@uab.edu |
| Contact: Jeff Worrell, RN, BSN, MPPM | 205-975-2098 | jworrell@uab.edu |
| United States, Alabama | |
| University of Alabama at Birmingham | Recruiting |
| Birmingham, Alabama, United States, 35249 | |
| Contact: Debbie Owen, BS 205-975-2088 debbieo@uab.edu | |
| Contact: Jeff Worrell, RN, BSN, MPPM 205-975-2098 jworrell@uab.edu | |
| Principal Investigator: Michael Froelich, MD, MS | |
| Sub-Investigator: Jason McKeown, MD | |
| Sub-Investigator: Georg Deutsch, MD, PhD | |
| Principal Investigator: | Michael Froelich, MD, MS | University of Alabama at Birmingham |
More Information
| Responsible Party: | University of Alabama at Birmingham ( Michael Froelich/Associate Professor ) |
| Study ID Numbers: | F061204014 |
| Study First Received: | April 14, 2008 |
| Last Updated: | November 2, 2009 |
| ClinicalTrials.gov Identifier: | NCT00659633 History of Changes |
| Health Authority: | United States: Food and Drug Administration; United States: Institutional Review Board |
|
lidocaine allodynia chronic regional pain syndrome pain |
|
Sensory System Agents Therapeutic Uses Physiological Effects of Drugs Lidocaine Central Nervous System Depressants Anesthetics |
Cardiovascular Agents Anti-Arrhythmia Agents Peripheral Nervous System Agents Central Nervous System Agents Pharmacologic Actions Anesthetics, Local |